Teladoc Health, Inc. (TDOC) vs Tempus AI, Inc. (TEM)
A side-by-side comparison of Teladoc Health, Inc. and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 8, 2026. Differences are shown without an overall score or investment verdict.
TDOC
Teladoc Health, Inc.
$7.13HealthcareAt close: Aug 7, 2026, 4:00 PM ET
TEM
Tempus AI, Inc.
$52.05HealthcareAt close: Aug 7, 2026, 4:00 PM ET
Total return — TDOC vs TEM
growth of $100 · dividends reinvested · last 2yTDOC -30.1%TEM +29.3%TEM compounded faster
TDOC TEM
TDOC vs TEM: by the numbers
- •TEM is the larger company ($9.12B vs $1.30B market cap).
- •Both run net losses; TDOC's is the smaller (-7.13% vs -17.77% net margin).
- •TEM grew revenue faster over the past five years (38.24% vs 8.85% CAGR).
Metrics side by side
Valuation
| Metric | TDOC | TEM |
|---|---|---|
| P/S ratio | 0.52 | 6.63 |
| P/B ratio | 0.98 | 21.34 |
| EV / EBITDA | 15.12 | N/A |
| FCF yield | 17.48% | N/A |
Profitability
| Metric | TDOC | TEM |
|---|---|---|
| Gross margin | 73.53% | 63.98% |
| Operating margin | -6.98% | -19.76% |
| Net margin | -7.13% | -17.77% |
| ROE | -13.54% | -57.18% |
| ROIC | -8.26% | -10.90% |
Growth (annualized)
| Metric | TDOC | TEM |
|---|---|---|
| Revenue CAGR (5Y) | 8.85% | 38.24% |
| FCF CAGR (5Y) | 25.56% | N/A |
| Total return CAGR (5Y) | -45.56% | N/A |
Frequently asked
- Which has grown faster, TDOC or TEM?
- Over the past five years, TEM grew revenue faster — TDOC at a 8.85% CAGR versus TEM at 38.24%.
Go deeper
Dig into the metrics
Teladoc Health P/E ratioTempus AI P/E ratioTeladoc Health dividend yieldTempus AI dividend yieldTeladoc Health ROETempus AI ROETeladoc Health operating marginTempus AI operating marginTeladoc Health revenue growthTempus AI revenue growthTeladoc Health free cash flowTempus AI free cash flow
Teladoc Health & Tempus AI appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 8, 2026.